Skip to content

688505.SH

Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd.

SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN

CNY 7.31
+2.24%
Ask drillr
  • Oct 9, 2026, 09:15 UTC

    Fudan Zhangjiang subscribed for a CNY 150 million Bank of China structured deposit using temporarily idle proceeds from its A-share public offering.

  • Aug 14, 2026, 10:32 UTC

    Fudan Zhangjiang Bio-Pharmaceutical reported interim results for the six months ended June 2026, with net profit of 36.895 million RMB, up 545% year-on-year.